The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Sterile Fill-Finish CMO Market Research Report 2024

Global Sterile Fill-Finish CMO Market Research Report 2024

Publishing Date : Sep, 2023

License Type :
 

Report Code : 1734485

No of Pages : 110

Synopsis
In pharmaceutical manufacturing, fill-finish operations are critical, since fill-finish is the last step before a product is packaged and ultimately delivered to the patient. By the time a drug reaches this stage, the drug product is highly valuable, as it has already been through labour- and cost-intensive production stages, including upstream processing, cell culture or fermentation and downstream purification. Failures in the integrity of the fill-finish stage can introduce microbial contamination and generate issues with formulation and dosing
Global Sterile Fill-Finish CMO market is projected to reach US$ 5137.1 million in 2029, increasing from US$ 3465 million in 2022, with the CAGR of 10.1% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Sterile Fill-Finish CMO market research.
The biologics sterile fill-finish services market is driven by the increasing demand for biopharmaceuticals and the outsourcing of fill-finish operations by pharmaceutical companies. As biologics continue to gain prominence in treating various diseases, there is a growing need for specialized services to ensure the safe and aseptic filling and packaging of these complex molecules. Contract manufacturing organizations (CMOs) offering sterile fill-finish services provide expertise, state-of-the-art facilities, and regulatory compliance, attracting pharmaceutical companies seeking cost-effective and efficient solutions. Additionally, the trend towards personalized medicine and the development of novel biologics further contribute to the market's expansion. However, the market also faces challenges, including the stringent regulatory landscape for biologics and the need to maintain strict quality control to avoid contamination and preserve product efficacy. As competition intensifies, CMOs must invest in advanced technologies and adhere to regulatory guidelines to gain a competitive edge and meet the growing demand for reliable biologics sterile fill-finish services.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Sterile Fill-Finish CMO market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Baxter BioPharma Solutions
Boehringer Ingelheim
Vetter Pharma
Fresenius Kabi
Pfizer CentreOne
Aenova
WuXi Biologics
Jubilant HollisterStier
Bushu Pharmaceuticals
LSNE Contract Manufacturing
Ajinomoto Bio-Pharma Services
CMIC CMO
GRAM (Grand River Aseptic Manufacturing)
TAIYO Pharma Tech Co.,Ltd.
HALIX
Cognate BioServices
Afton Scientific
Novasep
Emergent BioSolutions
Seikagaku
Jiangshu YAOHAI Bio-pharmaceutical
Akron Biotech
Symbiosis Pharmaceutical Services
Techdow
Vigene Biosciences
Segment by Type
Vials
Prefilled Syringes
Cartridges
Others
Segment by Application
Vaccines
Biologics
Biosimilar
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Sterile Fill-Finish CMO report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies' Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sterile Fill-Finish CMO Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Vials
1.2.3 Prefilled Syringes
1.2.4 Cartridges
1.2.5 Others
1.3 Market by Application
1.3.1 Global Sterile Fill-Finish CMO Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Vaccines
1.3.3 Biologics
1.3.4 Biosimilar
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Sterile Fill-Finish CMO Market Perspective (2018-2029)
2.2 Sterile Fill-Finish CMO Growth Trends by Region
2.2.1 Global Sterile Fill-Finish CMO Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Sterile Fill-Finish CMO Historic Market Size by Region (2018-2023)
2.2.3 Sterile Fill-Finish CMO Forecasted Market Size by Region (2024-2029)
2.3 Sterile Fill-Finish CMO Market Dynamics
2.3.1 Sterile Fill-Finish CMO Industry Trends
2.3.2 Sterile Fill-Finish CMO Market Drivers
2.3.3 Sterile Fill-Finish CMO Market Challenges
2.3.4 Sterile Fill-Finish CMO Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Sterile Fill-Finish CMO Players by Revenue
3.1.1 Global Top Sterile Fill-Finish CMO Players by Revenue (2018-2023)
3.1.2 Global Sterile Fill-Finish CMO Revenue Market Share by Players (2018-2023)
3.2 Global Sterile Fill-Finish CMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Sterile Fill-Finish CMO Revenue
3.4 Global Sterile Fill-Finish CMO Market Concentration Ratio
3.4.1 Global Sterile Fill-Finish CMO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sterile Fill-Finish CMO Revenue in 2022
3.5 Sterile Fill-Finish CMO Key Players Head office and Area Served
3.6 Key Players Sterile Fill-Finish CMO Product Solution and Service
3.7 Date of Enter into Sterile Fill-Finish CMO Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Sterile Fill-Finish CMO Breakdown Data by Type
4.1 Global Sterile Fill-Finish CMO Historic Market Size by Type (2018-2023)
4.2 Global Sterile Fill-Finish CMO Forecasted Market Size by Type (2024-2029)
5 Sterile Fill-Finish CMO Breakdown Data by Application
5.1 Global Sterile Fill-Finish CMO Historic Market Size by Application (2018-2023)
5.2 Global Sterile Fill-Finish CMO Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Sterile Fill-Finish CMO Market Size (2018-2029)
6.2 North America Sterile Fill-Finish CMO Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Sterile Fill-Finish CMO Market Size by Country (2018-2023)
6.4 North America Sterile Fill-Finish CMO Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Sterile Fill-Finish CMO Market Size (2018-2029)
7.2 Europe Sterile Fill-Finish CMO Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Sterile Fill-Finish CMO Market Size by Country (2018-2023)
7.4 Europe Sterile Fill-Finish CMO Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Sterile Fill-Finish CMO Market Size (2018-2029)
8.2 Asia-Pacific Sterile Fill-Finish CMO Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Sterile Fill-Finish CMO Market Size by Region (2018-2023)
8.4 Asia-Pacific Sterile Fill-Finish CMO Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Sterile Fill-Finish CMO Market Size (2018-2029)
9.2 Latin America Sterile Fill-Finish CMO Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Sterile Fill-Finish CMO Market Size by Country (2018-2023)
9.4 Latin America Sterile Fill-Finish CMO Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Sterile Fill-Finish CMO Market Size (2018-2029)
10.2 Middle East & Africa Sterile Fill-Finish CMO Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Sterile Fill-Finish CMO Market Size by Country (2018-2023)
10.4 Middle East & Africa Sterile Fill-Finish CMO Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Baxter BioPharma Solutions
11.1.1 Baxter BioPharma Solutions Company Detail
11.1.2 Baxter BioPharma Solutions Business Overview
11.1.3 Baxter BioPharma Solutions Sterile Fill-Finish CMO Introduction
11.1.4 Baxter BioPharma Solutions Revenue in Sterile Fill-Finish CMO Business (2018-2023)
11.1.5 Baxter BioPharma Solutions Recent Development
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Company Detail
11.2.2 Boehringer Ingelheim Business Overview
11.2.3 Boehringer Ingelheim Sterile Fill-Finish CMO Introduction
11.2.4 Boehringer Ingelheim Revenue in Sterile Fill-Finish CMO Business (2018-2023)
11.2.5 Boehringer Ingelheim Recent Development
11.3 Vetter Pharma
11.3.1 Vetter Pharma Company Detail
11.3.2 Vetter Pharma Business Overview
11.3.3 Vetter Pharma Sterile Fill-Finish CMO Introduction
11.3.4 Vetter Pharma Revenue in Sterile Fill-Finish CMO Business (2018-2023)
11.3.5 Vetter Pharma Recent Development
11.4 Fresenius Kabi
11.4.1 Fresenius Kabi Company Detail
11.4.2 Fresenius Kabi Business Overview
11.4.3 Fresenius Kabi Sterile Fill-Finish CMO Introduction
11.4.4 Fresenius Kabi Revenue in Sterile Fill-Finish CMO Business (2018-2023)
11.4.5 Fresenius Kabi Recent Development
11.5 Pfizer CentreOne
11.5.1 Pfizer CentreOne Company Detail
11.5.2 Pfizer CentreOne Business Overview
11.5.3 Pfizer CentreOne Sterile Fill-Finish CMO Introduction
11.5.4 Pfizer CentreOne Revenue in Sterile Fill-Finish CMO Business (2018-2023)
11.5.5 Pfizer CentreOne Recent Development
11.6 Aenova
11.6.1 Aenova Company Detail
11.6.2 Aenova Business Overview
11.6.3 Aenova Sterile Fill-Finish CMO Introduction
11.6.4 Aenova Revenue in Sterile Fill-Finish CMO Business (2018-2023)
11.6.5 Aenova Recent Development
11.7 WuXi Biologics
11.7.1 WuXi Biologics Company Detail
11.7.2 WuXi Biologics Business Overview
11.7.3 WuXi Biologics Sterile Fill-Finish CMO Introduction
11.7.4 WuXi Biologics Revenue in Sterile Fill-Finish CMO Business (2018-2023)
11.7.5 WuXi Biologics Recent Development
11.8 Jubilant HollisterStier
11.8.1 Jubilant HollisterStier Company Detail
11.8.2 Jubilant HollisterStier Business Overview
11.8.3 Jubilant HollisterStier Sterile Fill-Finish CMO Introduction
11.8.4 Jubilant HollisterStier Revenue in Sterile Fill-Finish CMO Business (2018-2023)
11.8.5 Jubilant HollisterStier Recent Development
11.9 Bushu Pharmaceuticals
11.9.1 Bushu Pharmaceuticals Company Detail
11.9.2 Bushu Pharmaceuticals Business Overview
11.9.3 Bushu Pharmaceuticals Sterile Fill-Finish CMO Introduction
11.9.4 Bushu Pharmaceuticals Revenue in Sterile Fill-Finish CMO Business (2018-2023)
11.9.5 Bushu Pharmaceuticals Recent Development
11.10 LSNE Contract Manufacturing
11.10.1 LSNE Contract Manufacturing Company Detail
11.10.2 LSNE Contract Manufacturing Business Overview
11.10.3 LSNE Contract Manufacturing Sterile Fill-Finish CMO Introduction
11.10.4 LSNE Contract Manufacturing Revenue in Sterile Fill-Finish CMO Business (2018-2023)
11.10.5 LSNE Contract Manufacturing Recent Development
11.11 Ajinomoto Bio-Pharma Services
11.11.1 Ajinomoto Bio-Pharma Services Company Detail
11.11.2 Ajinomoto Bio-Pharma Services Business Overview
11.11.3 Ajinomoto Bio-Pharma Services Sterile Fill-Finish CMO Introduction
11.11.4 Ajinomoto Bio-Pharma Services Revenue in Sterile Fill-Finish CMO Business (2018-2023)
11.11.5 Ajinomoto Bio-Pharma Services Recent Development
11.12 CMIC CMO
11.12.1 CMIC CMO Company Detail
11.12.2 CMIC CMO Business Overview
11.12.3 CMIC CMO Sterile Fill-Finish CMO Introduction
11.12.4 CMIC CMO Revenue in Sterile Fill-Finish CMO Business (2018-2023)
11.12.5 CMIC CMO Recent Development
11.13 GRAM (Grand River Aseptic Manufacturing)
11.13.1 GRAM (Grand River Aseptic Manufacturing) Company Detail
11.13.2 GRAM (Grand River Aseptic Manufacturing) Business Overview
11.13.3 GRAM (Grand River Aseptic Manufacturing) Sterile Fill-Finish CMO Introduction
11.13.4 GRAM (Grand River Aseptic Manufacturing) Revenue in Sterile Fill-Finish CMO Business (2018-2023)
11.13.5 GRAM (Grand River Aseptic Manufacturing) Recent Development
11.14 TAIYO Pharma Tech Co.,Ltd.
11.14.1 TAIYO Pharma Tech Co.,Ltd. Company Detail
11.14.2 TAIYO Pharma Tech Co.,Ltd. Business Overview
11.14.3 TAIYO Pharma Tech Co.,Ltd. Sterile Fill-Finish CMO Introduction
11.14.4 TAIYO Pharma Tech Co.,Ltd. Revenue in Sterile Fill-Finish CMO Business (2018-2023)
11.14.5 TAIYO Pharma Tech Co.,Ltd. Recent Development
11.15 HALIX
11.15.1 HALIX Company Detail
11.15.2 HALIX Business Overview
11.15.3 HALIX Sterile Fill-Finish CMO Introduction
11.15.4 HALIX Revenue in Sterile Fill-Finish CMO Business (2018-2023)
11.15.5 HALIX Recent Development
11.16 Cognate BioServices
11.16.1 Cognate BioServices Company Detail
11.16.2 Cognate BioServices Business Overview
11.16.3 Cognate BioServices Sterile Fill-Finish CMO Introduction
11.16.4 Cognate BioServices Revenue in Sterile Fill-Finish CMO Business (2018-2023)
11.16.5 Cognate BioServices Recent Development
11.17 Afton Scientific
11.17.1 Afton Scientific Company Detail
11.17.2 Afton Scientific Business Overview
11.17.3 Afton Scientific Sterile Fill-Finish CMO Introduction
11.17.4 Afton Scientific Revenue in Sterile Fill-Finish CMO Business (2018-2023)
11.17.5 Afton Scientific Recent Development
11.18 Novasep
11.18.1 Novasep Company Detail
11.18.2 Novasep Business Overview
11.18.3 Novasep Sterile Fill-Finish CMO Introduction
11.18.4 Novasep Revenue in Sterile Fill-Finish CMO Business (2018-2023)
11.18.5 Novasep Recent Development
11.19 Emergent BioSolutions
11.19.1 Emergent BioSolutions Company Detail
11.19.2 Emergent BioSolutions Business Overview
11.19.3 Emergent BioSolutions Sterile Fill-Finish CMO Introduction
11.19.4 Emergent BioSolutions Revenue in Sterile Fill-Finish CMO Business (2018-2023)
11.19.5 Emergent BioSolutions Recent Development
11.20 Seikagaku
11.20.1 Seikagaku Company Detail
11.20.2 Seikagaku Business Overview
11.20.3 Seikagaku Sterile Fill-Finish CMO Introduction
11.20.4 Seikagaku Revenue in Sterile Fill-Finish CMO Business (2018-2023)
11.20.5 Seikagaku Recent Development
11.21 Jiangshu YAOHAI Bio-pharmaceutical
11.21.1 Jiangshu YAOHAI Bio-pharmaceutical Company Detail
11.21.2 Jiangshu YAOHAI Bio-pharmaceutical Business Overview
11.21.3 Jiangshu YAOHAI Bio-pharmaceutical Sterile Fill-Finish CMO Introduction
11.21.4 Jiangshu YAOHAI Bio-pharmaceutical Revenue in Sterile Fill-Finish CMO Business (2018-2023)
11.21.5 Jiangshu YAOHAI Bio-pharmaceutical Recent Development
11.22 Akron Biotech
11.22.1 Akron Biotech Company Detail
11.22.2 Akron Biotech Business Overview
11.22.3 Akron Biotech Sterile Fill-Finish CMO Introduction
11.22.4 Akron Biotech Revenue in Sterile Fill-Finish CMO Business (2018-2023)
11.22.5 Akron Biotech Recent Development
11.23 Symbiosis Pharmaceutical Services
11.23.1 Symbiosis Pharmaceutical Services Company Detail
11.23.2 Symbiosis Pharmaceutical Services Business Overview
11.23.3 Symbiosis Pharmaceutical Services Sterile Fill-Finish CMO Introduction
11.23.4 Symbiosis Pharmaceutical Services Revenue in Sterile Fill-Finish CMO Business (2018-2023)
11.23.5 Symbiosis Pharmaceutical Services Recent Development
11.24 Techdow
11.24.1 Techdow Company Detail
11.24.2 Techdow Business Overview
11.24.3 Techdow Sterile Fill-Finish CMO Introduction
11.24.4 Techdow Revenue in Sterile Fill-Finish CMO Business (2018-2023)
11.24.5 Techdow Recent Development
11.25 Vigene Biosciences
11.25.1 Vigene Biosciences Company Detail
11.25.2 Vigene Biosciences Business Overview
11.25.3 Vigene Biosciences Sterile Fill-Finish CMO Introduction
11.25.4 Vigene Biosciences Revenue in Sterile Fill-Finish CMO Business (2018-2023)
11.25.5 Vigene Biosciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’